
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Beam Therapeutics seeks a highly motivated individual to join us as Manager, Raw Materials Planning as part of our Supply Chain team. You will play a key role in ensuring production readiness at the Beam NC site from a holistic Supply Chain perspective for Beam’s Liver portfolio, including production planning, raw materials planning, purchasing, and vendor management to ensure uninterrupted supply of raw materials in support of internal manufacturing of Liver Drug Product or Critical Materials. The role will be integral to growing the raw materials planning, inventory management, and production planning capabilities for Beam’s manufacturing site in North Carolina. Collaboration with the site’s Supply Chain, Operational Readiness, IT, and Manufacturing functions will be critical for the success of this role.
The ideal candidate will have experience working in a dynamic environment. They will also be able to successfully interface with multidisciplinary teams and build strong cross-functional relationships.
Responsibilities:
Qualifications:
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other